CPhI Worldwide, organised by Ubm emea, announce the winners of the distinguished 2016 CPhI Pharma Awards live at a dedicated gala dinner in the Fairmont Rey Juan Carlos I, Barcelona.
Udit Batra, Ph.D., Member of the Executive Board of Merck and CEO, the life science business of Merck* [*known as MilliporeSigma in the United States and Canada] won the prestigious Excellence in Pharma: CEO of the Year award.
In the ‘API Development’ category, Cambrex’s Novel Synthesis of Dronedarone Intermediate provided a patentable, 4-step, convergent process that utilises standard plant equipment – removing all need for chlorinated solvents and minimising waste.
The ‘Excipients and Formulations’ category saw two triumphant companies. Parteck® SRP 80 Excipient by Merck* was recognised for sustained-release oral solid dose matrix tablets in the excipients category.
Pylote’s Pycleartm protection patient Protection & Cost-Efficiency received the ‘Excellence in Pharma: Packaging’ award for its breakthrough industrial innovation that replaces preservatives in consumer end products.
In the ‘Drug Delivery Devices’ category, the 3M™ Intelligent Control Inhaler was honoured for its approach to addressing patient adherence and competence in Asthma and COPD patients.
The ‘Excellence in Pharma: Contract Services and Outsourcing’ award went to Catalent Pharma Solutions for its OptiForm Solution Suite and OptiForm Solution Suite Bio.
With its third award of the evening, Merck* Emprove® Program won in the ‘Regulatory Procedures and Compliance’ category.
FZC targeted the ‘Supply Chain, Logistics and Distribution’ challenges for its exemplary work in the MENA region through its Pharma Venture MENA – winning an award in this category.
Within ‘Analysis, Testing and Quality Control’, B&W Tek’s NanoLIBS® was victorious.
Novasep won the ‘Excellence in Pharma: Bioprocessing’ award with its BioSC® Lab – a DSP Purification Breakthrough for the Biopharma Industry.
Following the innovations in ‘Manufacturing Technology and Equipment’, winning GEA Group’s ConsiGma™ platform looks at the Future of Continuous Pharmaceutical Manufacturing.
Finally, the ‘Excellence in Pharma: Corporate Social Responsibility’ award went to Indena S.p.A.’s Centella asiatica for its Project in Madagascar.
Andreas Mavrommatis, Global Marketing Director at Ubm emea, added: “The CPhI Pharma Awards celebrates the entire pharma industry, its unique achievements, key people and technological innovations – it’s a celebration of everything that is best in our industry. In the last few years, we have seen an impressive increase in the number of entries, a growing appreciation of the overall value and prestige that winning an Award confers on a company, and, of course, a tremendous increase in the quality of emerging technologies submitted for consideration. On behalf of CPhI Worldwide and Ubm emea, I would like to commend all of the finalists and offer my warmest congratulations to this year’s worthy winners”
